Síndrome hemolítico urémico atípico secundario al uso de carfilzomib tratado con eculizumab / Eculizumab as a treatment for atypical hemolytic syndrome secondary to carfilzomib
Nefrología (Madrid)
; 39(1): 86-88, ene.-feb. 2019. tab
Article
in Es
| IBECS
| ID: ibc-181915
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
No disponible
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Antibodies, Monoclonal, Humanized
/
Proteasome Inhibitors
/
Atypical Hemolytic Uremic Syndrome
Limits:
Aged
/
Female
/
Humans
Language:
Es
Journal:
Nefrología (Madrid)
Year:
2019
Document type:
Article